Home › Non-Hodgkin Lymphoma › New York › Buffalo
Non-Hodgkin Lymphoma clinical trials in Buffalo, NY
7 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Roswell Park Comprehensive Cancer Center, Buffalo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Roswell Park Cancer Institute, Buffalo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Buffalo
Non-Hodgkin Lymphoma trials in other cities
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Atlanta, GA18 studies
- Milwaukee, WI18 studies
- Chicago, IL18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Other studies in Buffalo
- Non-Small Cell Lung Cancer19 studies
- Cancer (all types)19 studies
- Acute Myeloid Leukemia19 studies
- Lung Cancer16 studies
- Breast Cancer16 studies
- Ovarian Cancer13 studies
- Metastatic Cancer11 studies
- Prostate Cancer11 studies
- Melanoma10 studies
- Multiple Myeloma10 studies
- Obesity9 studies
- Burkitt Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.